EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019

This list contains a non-exhaustive inventory of hazardous substances for purposes of Regulation (EU) 2017/746, including Chap. 2 (Placing on the market and putting into service) and Annex I (General Safety and Performance Requirements). It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 17 május 2024. Database contains 4917 unique substances/entries.

Filter the list

4 917 eredményből 3 001 - 3 200 megmutatása.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC	EU REACH: List of SVHC
lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide LI-BIT	411-690-1	111337-53-2	Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1			Details
lithium bis(trifluoromethylsulfonyl)imide BIS TRIFLUOROMETHANE SULFONIMIDE LITHIUM; FLUORAD BRAND LITHIUM TRIFLUOROMETHANESULPHONIMIDE HQ-115	415-300-0	90076-65-6	Acute Tox. 3; STOT RE 2; Skin Corr. 1B			Details
lithium methanolate; lithium methoxide	212-737-7	865-34-9	Self-heat. 1; Skin Corr. 1B			Details
lithium nickel dioxide	620-400-4	12031-65-1	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate	249-644-6	29457-72-5	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.			Details
lithium potassium sodium N,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo)]naphthalene-1,3,6-trisulfonato}-N'-(2-aminoethyl)piperazine	427-850-9	202667-43-4	Skin Sens. 1			Details
lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) ACID RED FC 70013	414-250-7	149564-66-9	Acute Tox. 4; Eye Dam. 1			Details
lithium sodium 4,4', 4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate	429-730-1	193562-37-7	Eye Dam. 1; Skin Sens. 1			Details
lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate REACTIVE BLUE FC 05 717	401-560-2	108624-00-6	Skin Sens. 1			Details
Loa loa	-	-		P Parasites		Details
Louping ill	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
Lubricating greases; Grease [A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.] A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.	278-011-7	74869-21-9	Carc. 1B			Details
Lubricating oils (petroleum), base oils, paraffinic; Baseoil — unspecified [A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 °F (23cSt at 40 °C).] A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100°F (23cSt at 40°C).	297-474-6	93572-43-1	Carc. 1B			Details
Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based; Baseoil — unspecified [A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 °C. It contains a relatively large proportion of saturated hydrocabons.] A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40°C. It contains a relatively large proportion of saturated hydrocarbons.	276-737-9	72623-86-0	Carc. 1B			Details
Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated; Baseoil — unspecified [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 °C (104 °F.] A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produces a finished oil with a viscosity in the order of 17cSt to 23cSt at 40°C (104°F).	309-875-6	101316-70-5	Carc. 1B			Details
Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated; Baseoil — unspecified	295-423-2	92045-42-6	Carc. 1B			Details
Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed; Baseoil — unspecified	307-034-8	97488-95-4	Carc. 1B			Details
Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based; Baseoil — unspecified [A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370°C to 550 °C (698 °F to 1022°F).] A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370°C to 550°C (698°F to 1022°F).	305-594-8	94733-15-0	Carc. 1B			Details
Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based; Baseoil — unspecified [A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 °C to 550 °C (698 °F to 1022 °F).] A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370°C to 550°C (698°F to 1022°F).	305-595-3	94733-16-1	Carc. 1B			Details
Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated; Baseoil — unspecified [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 °C (104 °F).] A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40°C (104°F).	309-876-1	101316-71-6	Carc. 1B			Details
Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity; Baseoil — unspecified [A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and; solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 °C. It contains a relatively large proportion of saturated hydrocarbons.] A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40°C. It contains a relatively large proportion of saturated hydrocarbons.	276-736-3	72623-85-9	Carc. 1B			Details
Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based; Baseoil — unspecified [A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 °C. It contains a relatively large proportion of saturated hydrocarbons.] A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40°C. It contains a relatively large proportion of saturated hydrocarbons.	276-738-4	72623-87-1	Carc. 1B			Details
Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated; Baseoil — unspecified [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 °C (104 °F).] A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40°C (104°F).	309-877-7	101316-72-7	Carc. 1B			Details
Lubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated; Baseoil — unspecified [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 °C (212 °F).] A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100°C (212°F).	309-874-0	101316-69-2	Carc. 1B			Details
Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined; Baseoil — unspecified	295-424-8	92045-43-7	Carc. 1B			Details
Lubricating oils; Baseoil — unspecified [A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.] A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.	278-012-2	74869-22-0	Carc. 1B			Details
lufenuron (ISO); N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide CGA 184699	410-690-9	103055-07-8	Skin Sens. 1			Details
Lymphocytic (strains)	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
Lymphocytic choriomeningitis virus (other strains)	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
m-bis(2,3-epoxypropoxy)benzene; resorcinol diglycidyl ether	202-987-5	101-90-6	Carc. 1B; Muta. 2; Acute Tox. 3; Acute Tox. 4; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1			Details
m-cresol	203-577-9	108-39-4	Acute Tox. 3; Skin Corr. 1B			Details
m-mentha-1,3(8)-diene PRODUCT 5899	404-150-1	17092-80-7	Skin Irrit. 2			Details
m-nitroaniline	202-729-1	99-09-2	Acute Tox. 3; STOT RE 2			Details
m-phenylenediamine	203-584-7	108-45-2	Muta. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1			Details
m-phenylenediamine dihydrochloride	208-790-0	541-69-5	Muta. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1			Details
m-toluidine; 3-aminotoluene	203-583-1	108-44-1	Acute Tox. 3; STOT RE 2			Details
m-tolylidene diisocyanate; toluene-diisocyanate	247-722-4	26471-62-5	Carc. 2; Acute Tox. 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1			Details
m-xylene	203-576-3	108-38-3	Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2			Details
Machupo virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
Madurella grisea	-	-		F Fungi		Details
Madurella mycetomatis	-	-		F Fungi		Details
magnesium alkyls	-	-	Pyr. Liq. 1; Water-react. 1; Skin Corr. 1B			Details
magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) DUPLOSAN-DP-MAGNESIUM	413-360-2	164058-21-3	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1			Details
magnesium hexafluorosilicate	241-022-2	16949-65-8	Acute Tox. 3			Details
magnesium phosphide; trimagnesium diphosphide	235-023-7	12057-74-8	Water-react. 1; Acute Tox. 2; Acute Tox. 3; Acute Tox. 1			Details
magnesium powder (pyrophoric);magnesium, powder or turnings	231-104-6	7439-95-4	Water-react. 1; Pyr. Sol. 1			Details
magnesium powder (pyrophoric);magnesium, powder or turnings	231-104-6	7439-95-4	Flam. Sol. 1; Water-react. 2; Self-heat. 1			Details
magnesium sodium fluoride silicate	442-650-1	56450-90-9	STOT RE 2			Details
main component 1 (isomer 1):; 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 1 (isomer 2):; 2-{6-fluoro-4-[3-(2,5-disulfophenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt	422-610-1	-	Eye Dam. 1			Details
main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol; main component 8 (isomer):; asym. 1:2 Cr-complex of: A:; 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol BLACK UL 1253	417-280-9	30785-74-1	Eye Dam. 1			Details
Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III); by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfonyl)-3''-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III); by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III) BLACK JR 578	419-230-1	-	Skin Sens. 1			Details
malachite green hydrochloride	209-322-8	569-64-2	Repr. 2; Acute Tox. 4; Eye Dam. 1			Details
malachite green oxalate	219-441-7	2437-29-8	Repr. 2; Acute Tox. 4; Eye Dam. 1			Details
malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl O, O-dimethyl phosphorodithioate [containing ≤ 0,03 % isomalathion]	204-497-7	121-75-5	Acute Tox. 4; Skin Sens. 1			Details
maleic acid	203-742-5	110-16-7	Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1			Details
maleic anhydride	203-571-6	108-31-6	Acute Tox. 4; STOT RE 1; Skin Corr. 1B; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1A			Details
malononitrile	203-703-2	109-77-3	Acute Tox. 3			Details
mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt	616-995-5	8018-01-7	Carc. 2; Repr. 1B; STOT RE 2; Skin Sens. 1			Details
maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric)	235-654-8	12427-38-2	Repr. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1			Details
manganese dioxide	215-202-6	1313-13-9	Acute Tox. 4			Details
manganese sulphate	232-089-9	7785-87-7	STOT RE 2			Details
mannitol hexanitrate; nitromannite;mannitol hexanitrate; nitromannite;[>40 % phlegmatiser]	239-924-6	15825-70-4	Unst. Expl.			Details
mannitol hexanitrate; nitromannite;mannitol hexanitrate; nitromannite;[>40 % phlegmatiser]	239-924-6	15825-70-4	Expl. 1.1			Details
Mansonella ozzardi	-	-		P Parasites		Details
Mansonella perstans	-	-		P Parasites		Details
Marburg virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
Margosa, ext. [from the kernels of Azadirachta indica extracted with water and further processed with organic solvents] Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Azadirachta indica, Meliaceae.	283-644-7	84696-25-3	Repr. 2; Skin Sens. 1			Details
Mayaro virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
MCPA (ISO); 4-chloro-o-tolyloxyacetic acid	202-360-6	94-74-6	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
MCPA-thioethyl (ISO); S-ethyl (4-chloro-2-methylphenoxy)ethanethioate; S-ethyl 4-chloro-o-tolyloxythioacetate	246-831-4	25319-90-8	Acute Tox. 4			Details
Measles virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
mecarbam (ISO); N-ethoxycarbonyl-N-methylcarbamoylmethyl O, O-diethyl phosphorodithioate	219-993-9	2595-54-2	Acute Tox. 3			Details
mecetronium etilsulfate; N-ethyl-N,N-dimethylhexadecan-1-aminium ethyl sulfate; mecetronium ethyl sulphate; [MES]	221-106-5	3006-10-8	Skin Corr. 1; Eye Dam. 1			Details
mecoprop-P (ISO) and its salts; (R)-2-(4-chloro-2-methylphenoxy) propionic acid and its salts	-	-	Acute Tox. 4; Eye Dam. 1			Details
mecrilate; methyl 2-cyanoacrylate	205-275-2	137-05-3	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2			Details
medinoterb acetate (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate	219-634-6	2487-01-6	Acute Tox. 3; Acute Tox. 4			Details
Medium-chain chlorinated paraffins (MCCP) UVCB substances consisting of more than or equal to 80% linear chloroalkanes with carbon chain lengths within the range from C14 to C17 show/hide di-, tri- and tetrachlorotetradecane EC / List no: 950-299-5 \| CAS no: - Alkanes, C14-16, chloro EC / List no: 701-376-5 \| CAS no: 1372804-76-6 Alkanes, C14-17, chloro EC / List no: 287-477-0 \| CAS no: 85535-85-9 Tetradecane, chloro derivs. EC / List no: - \| CAS no: 198840-65-2	799-971-8	-			PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)	Details
menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonicacid, compound with nicotin-3-amide (1:1)	277-543-7	73581-79-0	Eye Irrit. 2; Skin Irrit. 2			Details
menadione sodium bisulfite; 2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt	204-987-0	130-37-0	Eye Irrit. 2; Skin Irrit. 2			Details
menazon (ISO); S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyl phosphorodithioate	201-123-4	78-57-9	Acute Tox. 4			Details
mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine	432-140-7	110235-47-7	Carc. 2			Details
mephosfolan (ISO); diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate	213-447-3	950-10-7	Acute Tox. 1; Acute Tox. 2			Details
mepiquat chloride (ISO); 1,1-dimethylpiperidinium chloride	246-147-6	24307-26-4	Acute Tox. 4; Acute Tox. 3			Details
mequinol; 4-methoxyphenol; hydroquinone monomethyl ether	205-769-8	150-76-5	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1			Details
mercaptodimethur (ISO); methiocarb (ISO); 3,5-dimethyl-4-methylthiophenyl N-methylcarbamate	217-991-2	2032-65-7	Acute Tox. 3			Details
mercury	231-106-7	7439-97-6	Repr. 1B; Acute Tox. 2; STOT RE 1			Details
mercury dichloride; mercuric chloride	231-299-8	7487-94-7	Muta. 2; Repr. 2; Acute Tox. 2; STOT RE 1; Skin Corr. 1B			Details
mercury difulminate; mercuric fulminate; fulminate of mercury;mercury difulminate; mercuric fulminate; fulminate of mercury [≥ 20 % phlegmatiser]	211-057-8	628-86-4	Unst. Expl.; Acute Tox. 3; STOT RE 2			Details
mercury difulminate; mercuric fulminate; fulminate of mercury;mercury difulminate; mercuric fulminate; fulminate of mercury [≥ 20 % phlegmatiser]	211-057-8	628-86-4	Expl. 1.1; Acute Tox. 3; STOT RE 2			Details
mesitylene; 1,3,5-trimethylbenzene	203-604-4	108-67-8	Flam. Liq. 3; STOT SE 3			Details
mesotrione(ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione	600-533-4	104206-82-8	Repr. 2; STOT RE 2			Details
metaflumizone (ISO); (E)-2-[2-(4-cyanophenyl)-1-(a,a,a -trifluoro-m-tolyl) ethylidene]-[4-(trifluoro-methoxy)phenyl]carbani-lohydrazide [2]	701-454-9	852403-68-0	Repr. 2; Lact.; STOT RE 2			Details
metaflumizone (ISO); (EZ)-2-[2-(4-cyanophe-nyl)-1-(a,a,a -trifluoro-m-tolyl)ethylidene]-[4-(tri-fluoromethoxy)phenyl] carbanilohydrazide [E-iso-mer > 90 %, Z-isomer <10 % relative content]	604-167-6	139968-49-3	Repr. 2; Lact.; STOT RE 2			Details
metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 4			Details
metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate	260-979-7	57837-19-1	Acute Tox. 4; Skin Sens. 1			Details
metalaxyl-M (ISO); mefenoxam; (R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester	615-135-6	70630-17-0	Acute Tox. 4; Eye Dam. 1			Details
metam-sodium (ISO); sodium methyldithiocarbamate	205-293-0	137-42-8	Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1			Details
metamitron (ISO);4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one	255-349-3	41394-05-2	Acute Tox. 4			Details
metazachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)-acetamide	266-583-0	67129-08-2	Skin Sens. 1B; Carc. 2			Details
metconazole (ISO); (1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol	603-031-3	125116-23-6	Repr. 2; Acute Tox. 4			Details
methacrifos (ISO); methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate	630-448-8	62610-77-9	Acute Tox. 4; Skin Sens. 1			Details
methacrylic acid; 2-methylpropenoic acid	201-204-4	79-41-4	Acute Tox. 4; Skin Corr. 1A			Details
methacrylonitrile; 2-methyl-2-propene nitrile	204-817-5	126-98-7	Flam. Liq. 2; Acute Tox. 3; Skin Sens. 1			Details
methamidophos (ISO); O,S-dimethyl phosphoramidothioate	233-606-0	10265-92-6	Acute Tox. 2; Acute Tox. 3			Details
methane	200-812-7	74-82-8	Flam. Gas 1; Press. Gas			Details
methanesulphonic acid	200-898-6	75-75-2	Skin Corr. 1B			Details
methanethiol; methyl mercaptan	200-822-1	74-93-1	Flam. Gas 1; Press. Gas; Acute Tox. 3			Details
methanol	200-659-6	67-56-1	Flam. Liq. 2; Acute Tox. 3; STOT SE 1			Details
methenamine; hexamethylenetetramine	202-905-8	100-97-0	Flam. Sol. 2; Skin Sens. 1			Details
methidathion (ISO); 2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate	213-449-4	950-37-8	Acute Tox. 2; Acute Tox. 4			Details
methomyl (ISO); 1-(methylthio)ethylideneamino N-methylcarbamate	240-815-0	16752-77-5	Acute Tox. 2			Details
methoxyacetic acid	210-894-6	625-45-6	Repr. 1B; Acute Tox. 4; Skin Corr. 1B		R Toxic for reproduction (article 57c)	Details
methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate GR138766X	415-670-3	78850-37-0	Eye Dam. 1			Details
methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate	445-990-9	376588-17-9	Skin Sens. 1			Details
methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate HALOXYFOP R-(+)-ME HERBICIDAL CHEMICAL	406-250-0	72619-32-0	Acute Tox. 4			Details
methyl (R)-2-(4-hydroxyphenoxy)propionate DHPPME; MAK-ME; MEHPOPS; R-MAQ-ME	411-950-4	96562-58-2	Eye Dam. 1			Details
methyl (R)-lactate	241-420-6	17392-83-5	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3			Details
methyl (S)-(-)-lactate	248-704-9	27871-49-4	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3			Details
methyl (±)-lactate;methyl lactate	208-930-0	2155-30-8;547-64-8	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3			Details
methyl (±)-lactate;methyl lactate	208-930-0	2155-30-8;547-64-8	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3			Details
methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate	432-350-9	81752-87-6	Skin Irrit. 2			Details
methyl 2,5-dichlorobenzoate	220-815-7	2905-69-3	Acute Tox. 4; STOT SE 3			Details
methyl 2-(2-nitrobenzylidene)acetoacetate 2-NITROBENZYLIDENE METHYL ESTER; BAY O 2787	400-650-9	39562-27-1	Skin Sens. 1			Details
methyl 2-(3-nitrobenzylidene)acetoacetate BM	405-270-7	39562-17-9	Skin Sens. 1			Details
methyl 2-(acetylamino)-3-chloropropionate	442-860-3	87333-22-0	Skin Sens. 1			Details
methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate DISPERSE RED CLA 282	416-240-8	155522-12-6	Skin Sens. 1			Details
methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate JE 127	421-220-7	144740-59-0	Skin Sens. 1			Details
methyl 2-benzylidene-3-oxobutyrate LUGALVAN ES 9571	420-940-9	15768-07-7	Eye Irrit. 2; Skin Irrit. 2			Details
methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate	443-120-2	393509-79-0	Eye Dam. 1			Details
methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate MEFAT	404-130-2	105560-93-8	Eye Dam. 1; Skin Sens. 1			Details
methyl 3,4-dichlorophenylcarbanilate; SWEP.	620-362-9	1918-18-9	Acute Tox. 4			Details
methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate G 18-1108	403-270-1	6386-39-6	Acute Tox. 4			Details
methyl 3-(acetylthio)-2-methyl-propanoate D,L-ESTER	411-040-7	97101-46-7	Acute Tox. 4; Skin Sens. 1			Details
methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate	250-366-2	30864-28-9	Acute Tox. 4; Skin Sens. 1			Details
methyl 3-amino-2,2,3-trimethylbutyrate	431-720-7	90886-53-6	Skin Corr. 1B; Acute Tox. 4			Details
methyl 3-amino-4,6-dibromo-2-methyl-benzoate	425-190-6	119916-05-1	STOT RE 2			Details
methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate F7641; MTSI	410-550-7	79277-18-2	STOT RE 2; Resp. Sens. 1; Skin Sens. 1			Details
methyl 3-sulphamoyl-2-thenoate A5546	402-050-2	59337-93-8	Skin Sens. 1			Details
methyl 4-bromomethyl-3-methoxybenzoate BROMBENZOAT; BROMOBENZOATE	410-310-1	70264-94-7	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1			Details
methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate MAT 9460	414-080-3	117291-73-3	Acute Tox. 4			Details
methyl acetate	201-185-2	79-20-9	Flam. Liq. 2; Eye Irrit. 2; STOT SE 3			Details
methyl acetoacetate	203-299-8	105-45-3	Eye Irrit. 2			Details
methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide) MAGME(R) 200 MONOMER	403-230-3	77402-05-2	Carc. 1B; Muta. 1B; Skin Corr. 1B; Skin Sens. 1			Details
methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid) MAGME 100 MONOMEER	401-890-7	77402-03-0	Carc. 1B; Muta. 1B; Acute Tox. 4; Eye Irrit. 2			Details
methyl acrylate; methyl propenoate	202-500-6	96-33-3	Flam. Liq. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1			Details
methyl chloroacetate	202-501-1	96-34-4	Flam. Liq. 3; Acute Tox. 3; STOT SE 3; Skin Irrit. 2; Eye Dam. 1			Details
methyl chloroformate	201-187-3	79-22-1	Flam. Liq. 2; Acute Tox. 2; Acute Tox. 4; Skin Corr. 1B			Details
methyl formate	203-481-7	107-31-3	Flam. Liq. 1; Acute Tox. 4; Eye Irrit. 2; STOT SE 3			Details
methyl iodide; iodomethane	200-819-5	74-88-4	Carc. 2; Acute Tox. 4; Acute Tox. 3; STOT SE 3; Skin Irrit. 2			Details
methyl isocyanate	210-866-3	624-83-9	Flam. Liq. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; Resp. Sens. 1; Skin Sens. 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1			Details
methyl isothiocyanate	209-132-5	556-61-6	Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1			Details
methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate	201-297-1	80-62-6	Flam. Liq. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1			Details
methyl N-(isopropoxycarbonyl)-L-valyl-(3RS)-3-(4-chlorophenyl)-β-alaninate; valifenalate	608-192-3	283159-90-0	Carc. 2			Details
methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate FAT 40'489	413-040-2	149850-30-6	Skin Sens. 1			Details
methyl neodecanamide	414-460-9	105726-67-8	Acute Tox. 4			Details
methyl propionate	209-060-4	554-12-1	Flam. Liq. 2; Acute Tox. 4			Details
methyl salicylate	204-317-7	119-36-8	Repr. 2; Acute Tox. 4; Skin Sens. 1B			Details
methyl tetrahydro-2-furancarboxylate METHFAT	420-670-1	37443-42-8	Eye Dam. 1			Details
methyl vinyl ether	203-475-4	107-25-5	Flam. Gas 1; Press. Gas			Details
methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate F5384	401-340-6	83055-99-6	Skin Sens. 1			Details
methyl-2,3,5,6-tetrachloro-4- pyridylsulphone;2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine	236-035-5	13108-52-6	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1			Details
methyl-2-[(aminosulfonyl)methyl]benzoate N 5297	419-010-5	112941-26-1	Acute Tox. 4; Eye Irrit. 2			Details
methyl-3-methoxyacrylate BETA-METHOXYACRYLSÄURE METHYLESTER	412-900-4	5788-17-0	Skin Sens. 1			Details
methyl-5-nitrophenyl-guanidine	435-500-1	152460-07-6	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1			Details
methyl-ONN-azoxymethyl acetate; methyl azoxy methyl acetate	209-765-7	592-62-1	Carc. 1B; Repr. 1B			Details
methyl-phenylene diamine	246-910-3	25376-45-8	Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1			Details
methylcyclohexane	203-624-3	108-87-2	Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3			Details
methylene dithiocyanate	228-652-3	6317-18-6	Acute Tox. 2; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1			Details
methylenediphenyl diisocyanate	247-714-0	26447-40-5	Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1			Details
methylethylketone peroxide trimer	429-320-2	24748-23-0	Org. Perox. B; Asp. Tox. 1; Skin Irrit. 2; Skin Sens. 1			Details
methylhydrazine	200-471-4	60-34-4	Carc. 1B			Details
methylmercuric chloride	204-064-2	115-09-3	Carc. 2; Repr. 1A; Lact.; Acute Tox. 2; STOT RE 1			Details
methyltriphenylphosphonium chloride METHYL-TPP-CHLORID; MTPP-CHLORID	418-400-2	1031-15-8	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
metolcarb (ISO); m-tolyl methylcarbamate; MTMC	214-446-0	1129-41-5	Acute Tox. 4			Details
metosulam (ISO); N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a] pyrimidine-2-sulfonamide	410-240-1	139528-85-1	Carc. 2; STOT RE 2			Details
metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one	244-209-7	21087-64-9	Acute Tox. 4; STOT RE 2			Details
mevinphos (ISO); 2-methoxycarbonyl-1-methylvinyl dimethyl phosphate	232-095-1	7786-34-7	Acute Tox. 1; Acute Tox. 2			Details
mexacarbate (ISO); 3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate	206-249-3	315-18-4	Acute Tox. 2; Acute Tox. 4			Details
Microsporum spp.	-	-		F Fungi		Details
milbemectin (ISO) [reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]	-	-	Acute Tox. 4			Details
Milkers' node virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
millerite	-	1314-04-1	Carc. 1A; Muta. 2; STOT RE 1; Skin Sens. 1			Details
Mineral wool, with the exception of those specified elsewhere in this Annex [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] show/hide Glass, oxide, chemicals This category encompasses the various chemical substances manufactured in the production of inorganic glasses. For purposes of this category, 'glass' is defined as an amorfous, inorganic, transparent, translucent or opaque material traditionally formed by fusion of sources of silica with a flux, such as an alkali-metal carbonate, boron oxide, etc. and a stabilizer, into a mass which is cooled to a rigid condition without crystallization in the case of transparent or liquid-phase separated glass or with controlled crystallization in the case of glass-ceramics. The category consists of the various chemical substances, other than by-products or impurities, which are formed during the production of various glasses and concurrently incorporated into a glass mixture. All glasses contain one or more of these substances, but few, if any, contain all of them. The elements listed below are principally present as components of oxide systems but some may also be present as halides or chalcogenides, in multiple oxidation states, or in more complex compounds. Trace amounts of other oxides or chemical compounds may be present. Oxides of the first seven elements listed* comprise more than 95 percent, by weight, of the glass produced. @Aluminium@Lead@Boron@Lithium@Calcium@Manganese@Magnesium@Molybdenum@Potassium@Neodymium@Silicon@Nickel@Sodium*@Niobium@Antimony@Nitrogen@Arsenic@Phosphorus@Barium@Praseodymium@Bismuth@Rubidium@Cadmium@Selenium@Carbon@Silver@Cerium@Strontium@Cesium@Sulfur@Chromium@Tellurium@Cobalt@Tin@Copper@Titanium@Germanium@Tungsten@Gold@Uranium@Holmium@Vanadium@Iron@Zinc@Lanthanum@Zirconium EC / List no: 266-046-0 \| CAS no: 65997-17-3 Glass Wool EC / List no: - \| CAS no: 308066-92-4	-	-	Carc. 2			Details
mipafox (ISO); N,N'-di-isopropylphosphorodiamidic fluoride	206-742-3	371-86-8	STOT SE 1			Details
mix-cresol	215-293-2	1319-77-3	Acute Tox. 3; Skin Corr. 1B			Details
mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin NUPORE G45-10	420-480-9	158570-99-1	Skin Irrit. 2; Skin Sens. 1			Details
molinate (ISO);S-ethyl 1-perhydroazepinecarbothioate; S-ethyl perhydroazepine-1-carbothioate	218-661-0	2212-67-1	Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1			Details
molybdenum nickel hydroxide oxide phosphate	268-585-7	68130-36-9	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1			Details
molybdenum nickel oxide	-	12673-58-4	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
molybdenum nickel tetraoxide	238-034-5	14177-55-0	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
molybdenum trioxide	215-204-7	1313-27-5	Carc. 2; Eye Irrit. 2; STOT SE 3			Details
Monkeypox virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
mono-2-[2-(4-dibenzo[b, f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate ICI204636 HYDROGEN FUMARATE	415-180-1	773058-82-5	Acute Tox. 4; Eye Dam. 1			Details
mono-methylamine;mono-methylamine ... %	200-820-0	74-89-5	Flam. Gas 1; Press. Gas; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1			Details
mono-methylamine;mono-methylamine ... %	200-820-0	74-89-5	Flam. Liq. 1; Acute Tox. 4; Skin Corr. 1B			Details
mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate Z-22	415-880-5	779343-34-9	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1			Details
monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex	-	-	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2			Details
monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex	-	-	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2			Details
monobenzone; 4-hydroxyphenyl benzyl ether; hydroquinone monobenzyl ether	203-083-3	103-16-2	Eye Irrit. 2; Skin Sens. 1			Details
monocrotophos (ISO); dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate	230-042-7	6923-22-4	Muta. 2; Acute Tox. 2; Acute Tox. 3			Details

4 917 eredményből 3 001 - 3 200 megmutatása.

Export search results to:

EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 17 május 2024. Database contains 4917 unique substances/entries.

Footer Nav Items